These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10917415)

  • 1. Fluvoxamine concentrations in breast milk and in maternal and infant sera.
    Arnold LM; Suckow RF; Lichtenstein PK
    J Clin Psychopharmacol; 2000 Aug; 20(4):491-3. PubMed ID: 10917415
    [No Abstract]   [Full Text] [Related]  

  • 2. The amount of fluvoxamine in milk is unlikely to be a cause of adverse effects in breastfed infants.
    Kristensen JH; Hackett LP; Kohan R; Paech M; Ilett KF
    J Hum Lact; 2002 May; 18(2):139-43. PubMed ID: 12033075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvoxamine in breast-milk and infant development.
    Yoshida K; Smith B; Kumar RC
    Br J Clin Pharmacol; 1997 Aug; 44(2):210-1. PubMed ID: 9278215
    [No Abstract]   [Full Text] [Related]  

  • 4. Nefazodone in the breast milk of nursing mothers: a report of two patients.
    Dodd S; Maguire KP; Burrows GD; Norman TR
    J Clin Psychopharmacol; 2000 Dec; 20(6):717-8. PubMed ID: 11106156
    [No Abstract]   [Full Text] [Related]  

  • 5. Nonlinear pharmacokinetics of fluvoxamine and gender differences.
    Härtter S; Wetzel H; Hammes E; Torkzadeh M; Hiemke C
    Ther Drug Monit; 1998 Aug; 20(4):446-9. PubMed ID: 9712472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimates of nursing infant daily dose of fluoxetine through breast milk.
    Suri R; Stowe ZN; Hendrick V; Hostetter A; Widawski M; Altshuler LL
    Biol Psychiatry; 2002 Sep; 52(5):446-51. PubMed ID: 12242061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excretion of escitalopram in breast milk.
    Castberg I; Spigset O
    J Clin Psychopharmacol; 2006 Oct; 26(5):536-8. PubMed ID: 16974204
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction between fluvoxamine and cotinine or caffeine.
    Yoshimura R; Ueda N; Nakamura J; Eto S; Matsushita M
    Neuropsychobiology; 2002; 45(1):32-5. PubMed ID: 11803239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxetine in human milk.
    Begg EJ; Duffull SB; Saunders DA; Buttimore RC; Ilett KF; Hackett LP; Yapp P; Wilson DA
    Br J Clin Pharmacol; 1999 Aug; 48(2):142-7. PubMed ID: 10417489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic determination of fluvoxamine and fluvoxamino acid in human plasma.
    Ohkubo T; Shimoyama R; Otani K; Yoshida K; Higuchi H; Shimizu T
    Anal Sci; 2003 Jun; 19(6):859-64. PubMed ID: 12834224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of in vivo 5-HTT transporter occupancy by fluvoxamine.
    Takano A; Suhara T; Ichimiya T; Yasuno F; Suzuki K
    J Clin Psychopharmacol; 2006 Apr; 26(2):188-91. PubMed ID: 16633150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroxetine use during breast-feeding.
    Hendrick V; Stowe ZN; Altshuler LL; Hostetter A; Fukuchi A
    J Clin Psychopharmacol; 2000 Oct; 20(5):587-9. PubMed ID: 11001251
    [No Abstract]   [Full Text] [Related]  

  • 13. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk.
    Taddio A; Ito S; Koren G
    J Clin Pharmacol; 1996 Jan; 36(1):42-7. PubMed ID: 8932542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cigarette smoking on fluvoxamine pharmacokinetics in humans.
    Spigset O; Carleborg L; Hedenmalm K; Dahlqvist R
    Clin Pharmacol Ther; 1995 Oct; 58(4):399-403. PubMed ID: 7586931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excretion of fluvoxamine into breast milk.
    Hägg S; Granberg K; Carleborg L
    Br J Clin Pharmacol; 2000 Mar; 49(3):286-8. PubMed ID: 10718788
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of women suffering from depression who are either pregnant or breastfeeding.
    Yonkers KA
    Am J Psychiatry; 2007 Oct; 164(10):1457-9. PubMed ID: 17898329
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of caffeine on the kinetics of fluvoxamine and its major metabolite in plasma after a single oral dose of the drug.
    Fukasawa T; Yasui-Furukori N; Suzuki A; Ishii G; Inoue Y; Tateishi T; Otani K
    Ther Drug Monit; 2006 Jun; 28(3):308-11. PubMed ID: 16778712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the CYP 2D6 genotype and cigarette smoking on the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients.
    Gerstenberg G; Aoshima T; Fukasawa T; Yoshida K; Takahashi H; Higuchi H; Murata Y; Shimoyama R; Ohkubo T; Shimizu T; Otani K
    Ther Drug Monit; 2003 Aug; 25(4):463-8. PubMed ID: 12883230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine excretion in human breast milk: estimation of infant exposure.
    Croke S; Buist A; Hackett LP; Ilett KF; Norman TR; Burrows GD
    Int J Neuropsychopharmacol; 2002 Sep; 5(3):243-7. PubMed ID: 12366877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drowsiness and poor feeding in a breast-fed infant: association with nefazodone and its metabolites.
    Yapp P; Ilett KF; Kristensen JH; Hackett LP; Paech MJ; Rampono J
    Ann Pharmacother; 2000 Nov; 34(11):1269-72. PubMed ID: 11098340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.